Melatonin Does Not Prevent Delirium in the Intensive Care Unit: Insights from a Comprehensive Meta-Analysis
Highlights
– A comprehensive meta-analysis of 13 randomized controlled trials finds no benefit for melatonin in delirium prevention.
– Primary analysis restricted to low-to-moderate risk of bias studies confirms no significant reduction in delirium incidence (RR 0.89).
– Melatonin administration does not influence mortality rates among critically ill patients, suggesting a limited role for this hormone in acute recovery.
Introduction: The Burden of Delirium in Critical Care
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.